Isabel Aznarez

Founder at STOKE THERAPEUTICS, INC.

54 year

Consumer Services

Commercial Services

Health Technology

Profile

Dr. Isabel Aznarez is a Chief Technology Officer at Stoke Therapeutics, Inc. She is on the Board of Directors at Oligonucleotide Therapeutics Society, Inc. She received her undergraduate degree from Universidad De La Republica Uruguay and a doctorate degree from the University of Toronto.

Isabel Aznarez active positions

Companies	Position	Start
STOKE THERAPEUTICS, INC.	Founder	01/06/2014
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Director/Board Member	01/01/2019

All active positions of Isabel Aznarez

Training of Isabel Aznarez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Isabel Aznarez's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oligonucleotide Therapeutics Society, Inc. Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics	Commercial Services
Universidad De La Republica Uruguay Universidad De La Republica Uruguay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology